Search results
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoCorvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q4 2023 Earnings Call Transcript March 19, 2024 Corvus...
Individual investors among Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) largest shareholders, saw...
Simply Wall St. via Yahoo Finance· 12 months agoKey Insights Corvus Pharmaceuticals' significant individual investors ownership suggests that the...
Great news for Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS): Insiders acquired stock in large numbers...
Simply Wall St. via Yahoo Finance· 2 years agoIt is usually uneventful when a single insider buys stock. However, When quite a few insiders buy...
Q3 2023 Corvus Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 months agoParticipants Zach Kubow; IR; Real Chemistry Leiv Lea; CFO; Corvus Pharmaceuticals, Inc. Richard Miller; Co- founder, President & CEO; Corvus Pharmaceuticals, Inc. James Rosenbaum; SVP, Research ...
Corvus Pharmaceuticals Inc (CRVS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 3 weeks agoResearch and Development Expenses: Q1 2024: $4.1 million; Q1 2023: $4.6 million. Net Loss: Q1 2024: $5.7 million; Q1 2023: $7.9 million. Total Stock Compensation Expense: Q1 2024: $0.7 million ...
We Think Corvus Pharmaceuticals (NASDAQ:CRVS) Needs To Drive Business Growth Carefully
Simply Wall St. via Yahoo Finance· 3 months agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
Corvus Pharma's HIV Candidate Shows Potential To Prevent Virus Re-Emergence
Benzinga via Yahoo Finance· 1 year agoCorvus Pharmaceuticals Inc (NASDAQ: CRVS) announced new data demonstrating the potential of CPI-818,...
Corvus Pharma's Partner Secures China Approval For Early-Stage Mupadolimab Trial For Lung, Head &...
Benzinga via Yahoo Finance· 2 years agoThe China National Medical Products Administration signed off Corvus Pharmaceuticals Inc's (NASDAQ:...
Corvus Pharma (CRVS) Stock Surges 69.2% in a Week: Here's Why
Zacks via Yahoo Finance· 1 year agoShares of Corvus Pharma (CRVS) surge 69% this week after the company provided updates on its...
Insider Spends US$1m Buying More Shares In Corvus Pharmaceuticals
Simply Wall St. via Yahoo Finance· 3 weeks agoCorvus Pharmaceuticals, Inc. (NASDAQ:CRVS) shareholders (or potential shareholders) will be happy to...
